Health & Environmental Research Online (HERO)


Print Feedback Export to File
1431713 
Journal Article 
Decrease in pyrrole-2-carboxylic acid excretion during lung cancer disease 
Svojtkova, E; Deyl, Z; Andrlikova, J 
1982 
1 
Neoplasma
ISSN: 0028-2685
EISSN: 1338-4317 
HEEP/83/08173 
BRATISL 
BRATISL 
625-630 
English 
7177252 
HEEP COPYRIGHT: BIOL ABS. A statistically significant decrease of pyrrole-2-carboxylic acid in urine was observed in lung cancer of stage I (TNM (tumor-node-metastasis) classification) when compared to that of healthy miners (chronically exposed to radiation) from the uranium industry. The difference vanishes in stage II of the disease and reappears in stage III. While nonmalignant lung diseases (bronchopneumonia and chronic bronchitis) do not interfere in stage I with the drop of pyrrole-2-carboxylic acid excretion, in stage III of lung cancer the decrease is less pronounced and cannot be differentiated from that found in bronchopneumonia or chronic bronchitis. 
IRIS
• Uranium
     Toxline
     Merged reference set
     Secondary Refinement
          Retained for manual screening
     Excluded:
          Not chemical specific
     Uranium Literature Search Update 3/2017
          Toxnet